Literature DB >> 15727940

Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo.

Bakhos A Tannous1, Dong-Eog Kim, Juliet L Fernandez, Ralph Weissleder, Xandra O Breakefield.   

Abstract

Photoproteins have played a major role in advancing our understanding of biological processes. A broader array of biocompatible, nontoxic, and novel reporters can serve to expand this potential. Here we describe the properties of a luciferase from the copepod marine organism Gaussia princeps. It is a monomeric protein composed of 185 aa (19.9 kDa) with a short coding sequence (555 bp) making it suitable for viral vectors. The humanized form of Gaussia luciferase (hGLuc) was efficiently expressed in mammalian cells following delivery by HSV-1 amplicon vectors. It was found to be nontoxic and naturally secreted, with flash bioluminescence characteristics similar to those of other coelenterazine luciferases. hGLuc generated over 1000-fold higher bioluminescent signal intensity from live cells together with their immediate environment and over 100-fold higher intensity from viable cells alone (not including secreted luciferase) or cell lysates, compared to humanized forms of firefly (hFLuc) and Renilla (hRLuc) luciferases expressed under similar conditions. Furthermore, hGLuc showed 200-fold higher signal intensity than hRLuc and intensity comparable to that of hFLuc in vivo under standard imaging conditions. Gaussia luciferase provides a sensitive means of imaging gene delivery and other events in living cells in culture and in vivo, with a unique combination of features including high signal intensity, secretion, and ATP independence, thus being able to report from the cells and their environment in real time.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15727940     DOI: 10.1016/j.ymthe.2004.10.016

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  277 in total

1.  Secreted CXCL12 (SDF-1) forms dimers under physiological conditions.

Authors:  Paramita Ray; Sarah A Lewin; Laura Anne Mihalko; Sasha-Cai Lesher-Perez; Shuichi Takayama; Kathryn E Luker; Gary D Luker
Journal:  Biochem J       Date:  2012-03-01       Impact factor: 3.857

2.  Enhanced Gaussia luciferase blood assay for monitoring of in vivo biological processes.

Authors:  M Sarah S Bovenberg; M Hannah Degeling; Bakhos A Tannous
Journal:  Anal Chem       Date:  2011-12-27       Impact factor: 6.986

3.  Secreted luciferase for in vivo evaluation of systemic protein delivery in mice.

Authors:  Salim S El-Amouri; Phuong Cao; Carol Miao; Dao Pan
Journal:  Mol Biotechnol       Date:  2013-01       Impact factor: 2.695

4.  Evolution of poliovirus defective interfering particles expressing Gaussia luciferase.

Authors:  Yutong Song; Aniko V Paul; Eckard Wimmer
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

5.  A water-soluble coelenterazine for sensitive in vivo imaging of coelenterate luciferases.

Authors:  Danielle Morse; Bakhos A Tannous
Journal:  Mol Ther       Date:  2012-04       Impact factor: 11.454

6.  NFκB and HIF display synergistic behaviour during hypoxic inflammation.

Authors:  Ulrike Bruning; Susan F Fitzpatrick; Till Frank; Marc Birtwistle; Cormac T Taylor; Alex Cheong
Journal:  Cell Mol Life Sci       Date:  2011-11-09       Impact factor: 9.261

7.  Signaling active CD95 receptor molecules trigger co-translocation of inactive CD95 molecules into lipid rafts.

Authors:  Isabell Lang; Andrea Fick; Viktoria Schäfer; Tina Giner; Daniela Siegmund; Harald Wajant
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

8.  WLS-dependent secretion of WNT3A requires Ser209 acylation and vacuolar acidification.

Authors:  Gary S Coombs; Jia Yu; Claire A Canning; Charles A Veltri; Tracy M Covey; Jit K Cheong; Velani Utomo; Nikhil Banerjee; Zong Hong Zhang; Raquel C Jadulco; Gisela P Concepcion; Tim S Bugni; Mary Kay Harper; Ivana Mihalek; C Michael Jones; Chris M Ireland; David M Virshup
Journal:  J Cell Sci       Date:  2010-09-07       Impact factor: 5.285

9.  Bioorthogonal Protein Conjugation: Application to the Development of a Highly Sensitive Bioluminescent Immunoassay for the Detection of Interferon-γ.

Authors:  Angeliki Moutsiopoulou; Eric Hunt; David Broyles; Christie Ataides Pereira; Kristen Woodward; Emre Dikici; Angel Kaifer; Sylvia Daunert; Sapna K Deo
Journal:  Bioconjug Chem       Date:  2017-05-30       Impact factor: 4.774

10.  Fusion of Gaussia luciferase to an engineered anti-carcinoembryonic antigen (CEA) antibody for in vivo optical imaging.

Authors:  Katy M Venisnik; Tove Olafsen; Sanjiv S Gambhir; Anna M Wu
Journal:  Mol Imaging Biol       Date:  2007 Sep-Oct       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.